Glutamatergic Transmission in Brain Development and Disease
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Tissues and Organs".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 2797
Special Issue Editors
Interests: long-term consequences of prenatal exposure to cannabis; synaptic and network alterations associated with cognitive dysfunction in aging and Alzheimer’s disease; role of hyperexcitability in mediating neurodegeneration; identification of sensitive behavioral tasks for assessment of cognitive impairment; increasing research opportunities for underrepresented minorities
Interests: glutamatergic transmission; AMPA receptor; neuroscience
Interests: molecular mechanisms of synaptic deregulation and deficits in learning and memory in conditions (such as aging, diabetes, obesity, Alzheimer’s disease, prenatal alcohol exposure, prenatal nicotine exposure, and prenatal cannabinoid exposure)
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases are becoming more common as advanced medical techniques allow humans to age significantly. Among them are Alzheimer’s disease (AD), Parkinson’s disease (PD) and many more. These diseases affect millions throughout the world. In the US alone, an estimated 6.2 million people might be diagnosed with AD in the coming decade. According to recent studies, around 1 million people are currently living with PD and the number is expected to increase. These diseases generally occur as ageing progresses; however, numerous cases of early onset have also been noted. The pathophysiology of these diseases involves altered macro- and micro-structures of the neural networks in specific brain areas, known and unknown mutations in proteins and receptors leading to their misfolding or malfunction, overall neuronal damage, and loss of plasticity, as well as altered balance in the excitatory and inhibitory neurotransmission systems in the brain mainly controlled by glutamate and gamma-aminobutyric acid receptors. In this Special Issue dedicated to these complex disorders, we invite research articles and reviews from eminent researchers to disseminate their findings through our publication that are focused on novel and cutting-edge findings that investigate and answer questions about these diseases that are clinically and biologically significant.
Dr. Miranda Nicole Reed
Dr. Subhrajit Bhattacharya
Dr. Vishnu Suppiramaniam
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
